You are here

PNH

Alexion to Buy Achillion in $930M Marriage of Rare Disease Drug Firms

Xconomy

Wed, 10/16/19 - 12:48 pm

Alexion Pharmaceuticals

After rocky hep C path, Achillion finds surer footing with FDA breakthrough status

Endpoints

Wed, 09/25/19 - 11:32 pm

paroxysmal nocturnal hemoglobinuria

Alexion's beating forecasts with Soliris-to-Ultomiris switch. So what's up with its pesky stock price?

Fierce Pharma

Fri, 07/26/19 - 11:05 am

Alexion’s Soliris follow-up Ultomiris snares EU approval

Pharmaforum

Sun, 07/7/19 - 11:13 am

Alexion reports positive phase 3 extension data for ULTOMIRIS in paroxysmal nocturnal hemoglobinuria

Pharmaceutical Business Review

Mon, 06/17/19 - 10:03 am

Alexion Pharmaceuticals

4 Blockbuster Drug Launches to Watch in 2019

Motley Fool

Sun, 03/24/19 - 08:08 pm

Alexion Pharmaceuticals

Aimmune Therapeutics

rheumatoid arthritis

Alexion runs toward big Ultomiris goals with early Soliris switching success

Fierce Pharma

Tue, 02/5/19 - 11:17 pm

paroxysmal nocturnal hemoglobinuria

Alexion’s newly approved rare-disease drug notches another clinical trial win

Stat

Mon, 01/28/19 - 11:10 am

Alexion Pharmaceuticals

clinical trials

FDA approves new Alexion’s therapy targeting paroxysmal nocturnal hemoglobinuria

GoinPharma

Fri, 12/28/18 - 01:00 pm

Alexion wins approval for rare disease drug, aims to switch patients from blockbuster Soliris

Stat

Fri, 12/21/18 - 11:51 am

Alexion Pharmaceuticals

FDA Accepts Priority Review of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria

CP Wire

Mon, 08/20/18 - 11:40 am

Alexion Pharmaceuticals

paroxysmal nocturnal hemoglobinuria

Alexion's follow-on stacks up to Soliris

Biopharma Dive

Fri, 03/16/18 - 11:19 am

paroxysmal nocturnal hemoglobinuria

Akari CEO resigns amidst dodgy data claims

BioPharma Dive

Thu, 06/1/17 - 11:55 pm

Akari Therapeutics

clinical trials

The 'Soliris-killer' cometh? Alnylam plans final 2017 trials to take on world's priciest drug

BioPharma Dive

Fri, 12/11/15 - 10:58 am

Alnylam Going After World's Most Expensive Drug in New Trials

Bloomberg

Thu, 12/10/15 - 10:29 am

The Cure for Alexion

TheStreet.com

Wed, 02/22/12 - 11:02 am

Soliris Continues to Drive Growth as Alexion Adds to Its Pipeline

Morningstar

Sat, 02/12/11 - 02:42 pm

Alexion Hoping Its Soliris Is That Rare Wonder Drug

Investors.com

Fri, 07/16/10 - 08:22 am

Alexion: One-Trick Pony, But It's a Pretty Good Trick

Seeking Alpha

Thu, 06/3/10 - 08:56 pm

Alexion Accelerates Plans to Launch Soliris® (Eculizumab) in Japan

Yahoo

Wed, 06/2/10 - 08:23 am

Pages